Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("STUPP, B. Roger")

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

Haemopoietic growth factors and dose intensity in high-grade and intermediate-grade lymphomaPETTENGELL, R; CROWTHER, D.Annals of oncology. 1994, Vol 5, pp 133-141, issn 0923-7534, SUP2Conference Paper

The treatment of Hodgkin's diseaseROSENBERG, S. A.Annals of oncology. 1994, Vol 5, pp 17-21, issn 0923-7534, SUP2Conference Paper

Early bone marrow transplantation in Hodgkin's diseaseARMITAGE, J. O.Annals of oncology. 1994, Vol 5, pp 161-163, issn 0923-7534, SUP2Conference Paper

Modern treatment of malignant lymphomas : a multidisciplinary approach ? The Kaplan memorial lectureBONADONNA, G.Annals of oncology. 1994, Vol 5, pp 5-16, issn 0923-7534, SUP2Conference Paper

Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's diseaseNOORDIJK, E. M; CARDE, P; HENRY-AMAR, M et al.Annals of oncology. 1994, Vol 5, pp 107-112, issn 0923-7534, SUP2Conference Paper

Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphomaCANELLOS, G. P.Annals of oncology. 1994, Vol 5, pp 121-122, issn 0923-7534, SUP2Conference Paper

Low-grade lymphoma 1993 : state of the artHORNING, S. J.Annals of oncology. 1994, Vol 5, pp 23-27, issn 0923-7534, SUP2Conference Paper

Lymphoma complicating immunodeficiency disordersLEVINE, A. M.Annals of oncology. 1994, Vol 5, pp 29-35, issn 0923-7534, SUP2Conference Paper

Intensive conventional-dose chemotherapy for stage IV low-grade lymphoma : high remission rates and reversion to negative of peripheral blood bcl-2 rearrangementMCLAUGHLIN, P; HAGEMEISTER, F. B; SWAN, F et al.Annals of oncology. 1994, Vol 5, pp 73-77, issn 0923-7534, SUP2Conference Paper

The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapyHAGEMEISTER, F. B; PURUGGANAN, R; PODOLOFF, D. A et al.Annals of oncology. 1994, Vol 5, pp 59-63, issn 0923-7534, SUP2Conference Paper

Cost-benefit of granulocyte colony-stimulating factor administration in older patients with non-Hodgkin's lymphoma treated with combination chemotherapyZAGONEL, V; BABARE, R; MEROLA, M. C et al.Annals of oncology. 1994, Vol 5, pp 127-132, issn 0923-7534, SUP2Conference Paper

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas : results of a randomized double-blind placebo-controlled study with intensified COP-BLAM ± rhCM-CSFENGELHARD, M; GERHARTZ, H; LUDWIG, W.-D et al.Annals of oncology. 1994, Vol 5, pp 123-125, issn 0923-7534, SUP2Conference Paper

Stage, serum LDH, and performance status predict disease progression and survival in HIV-associated lymphomasHAGEMEISTER, F. B; KHETAN, R; ALLEN, P et al.Annals of oncology. 1994, Vol 5, pp 41-46, issn 0923-7534, SUP2Conference Paper

Autologous bone marrow transplantation for low-grade non-Hodgkin's lymphoma : the European Bone Marrow Transplant Group experienceSCHOUTEN, H. C; COLOMBAT, P; VERDONCK, L. F et al.Annals of oncology. 1994, Vol 5, pp 147-149, issn 0923-7534, SUP2Conference Paper

Chlorambucil/prednisone vs. CHOP in symptomatic low-grade non-Hodgkin's lymphomas : a randomized trial from the lymphoma group of central SwedenKIMBY, E; BJÖRKHOLM, M; KILLANDER, A et al.Annals of oncology. 1994, Vol 5, pp 67-71, issn 0923-7534, SUP2Conference Paper

EORTC study of non-Hodgkin's lymphoma : phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphomaSOMERS, R; CARDE, P; DUEZ, N et al.Annals of oncology. 1994, Vol 5, pp 85-89, issn 0923-7534, SUP2Conference Paper

Hodgkin's disease in children : combined modality treatment for stages IA, IB, and IIA : results in 356 patients of the German/Austrian Pediatric Study GroupSCHELLONG, G; BRÄMSWIG, J. H; HÖRNIG-FRANZ, I et al.Annals of oncology. 1994, Vol 5, pp 113-115, issn 0923-7534, SUP2Conference Paper

Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients : a case-controlled analysis of the EBMT Registry dataLIBERTI, G; PEARCE, R; TAGHIPOUR, G et al.Annals of oncology. 1994, Vol 5, pp 151-153, issn 0923-7534, SUP2Conference Paper

Early-stage Hodgkin's disease : long-term results with radiotherapy alone or combined radiotherapy and chemotherapyBRUSAMOLINO, E; LAZZARINO, M; CORBELLA, F et al.Annals of oncology. 1994, Vol 5, pp 101-106, issn 0923-7534, SUP2Conference Paper

High-dose therapy and autologous bone marrow transplantation in first complete remission for adult patients with high-grade non-Hodgkin's lymphoma : the EBMT experienceSWEETENHAM, J. W; PROCTOR, S. J; BLAISE, D et al.Annals of oncology. 1994, Vol 5, pp 155-159, issn 0923-7534, SUP2Conference Paper

Hybrid LOPP/EVA is not better than LOPP alternating with EVAP : a prematurely terminated British National Lymphoma Investigation randomized trialHANCOCK, B. W; VAUGHAN HUDSON, G; BAUGHAN HUDSON, B et al.Annals of oncology. 1994, Vol 5, pp 117-120, issn 0923-7534, SUP2Conference Paper

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for follicular lymphomaROHATINER, A. Z. S; FREEDMAN, A; NADLER, L et al.Annals of oncology. 1994, Vol 5, pp 143-146, issn 0923-7534, SUP2Conference Paper

A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's lymphoma : results of SWOG-8516 (Intergroup 0067), the National High-Priority Lymphoma StudyFISHER, R. I; GAYNOR, E. R; DAHLBERG, S et al.Annals of oncology. 1994, Vol 5, pp 91-95, issn 0923-7534, SUP2Conference Paper

Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapyBRUSAMOLINO, E; ORLANDI, E; MORRA, E et al.Annals of oncology. 1994, Vol 5, pp 53-57, issn 0923-7534, SUP2Conference Paper

Comparable prognostic factors and survival in elderly patients with aggressive non-Hodgkin's lymphoma treated with standard-dose adriamycin-based regimensGROGAN, L; CORBALLY, N; DERVAN, P. A et al.Annals of oncology. 1994, Vol 5, pp 47-51, issn 0923-7534, SUP2Conference Paper

  • Page / 2